<- Go Home
Fresh2 Group Limited
Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People’s Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. Further, it operates an e-commerce platform that connects food suppliers and supermarket operators and restaurant owners. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is based in New York, New York.
Market Cap
$32.3M
Volume
6.4K
Cash and Equivalents
$495.0K
EBITDA
-$115.6M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$9.2M
Profit Margin
54.38%
52 Week High
$120.58
52 Week Low
$7.91
Dividend
N/A
Price / Book Value
0.14
Price / Earnings
-0.05
Price / Tangible Book Value
1.20
Enterprise Value
$51.4M
Enterprise Value / EBITDA
-0.44
Operating Income
-$118.7M
Return on Equity
216.23%
Return on Assets
-61.97
Cash and Short Term Investments
$649.0K
Debt
$201.0K
Equity
$112.1M
Revenue
$17.0M
Unlevered FCF
-$38.9M
Sector
Biotechnology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium